Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients. 2020

Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
From the Departments of Anesthesiology and Intensive Care, Odense University Hospital-Svendborg Hospital, Svendborg (H.T.O.), the Departments of Clinical Research (H.T.O., H.K.N., T.S., J.O., P.T.) and Business and Economics (S.K., J.T.L.), University of Southern Denmark, and the Department of Anesthesiology and Intensive Care, Odense University Hospital (T.S., P.T.), Odense, the Department of Anesthesiology and Intensive Care, Hospital Lillebaelt, Kolding (H.K.N.), and the Department of Anesthesiology and Intensive Care, Esbjerg Hospital, Esbjerg (J.O.) - all in Denmark; the Department of Anesthesiology and Intensive Care, Vestfold Hospital, Tønsberg (K.-A.W.), and the Department of Anesthesiology and Intensive Care, University Hospital of North Norway, Tromsø (L.M.Y., B.A.K.) - both in Norway; and the Department of Anesthesiology and Intensive Care, Linköping University Hospital, Linköping, Sweden (M.C.).

In critically ill, mechanically ventilated patients, daily interruption of sedation has been shown to reduce the time on ventilation and the length of stay in the intensive care unit (ICU). Data on whether a plan of no sedation, as compared with a plan of light sedation, has an effect on mortality are lacking. In a multicenter, randomized, controlled trial, we assigned, in a 1:1 ratio, mechanically ventilated ICU patients to a plan of no sedation (nonsedation group) or to a plan of light sedation (i.e., to a level at which the patient was arousable, defined as a score of -2 to -3 on the Richmond Agitation and Sedation Scale [RASS], on which scores range from -5 [unresponsive] to +4 [combative]) (sedation group) with daily interruption. The primary outcome was mortality at 90 days. Secondary outcomes were the number of major thromboembolic events, the number of days free from coma or delirium, acute kidney injury according to severity, the number of ICU-free days, and the number of ventilator-free days. Between-group differences were calculated as the value in the nonsedation group minus the value in the sedation group. A total of 710 patients underwent randomization, and 700 were included in the modified intention-to-treat analysis. The characteristics of the patients at baseline were similar in the two trial groups, except for the score on the Acute Physiology and Chronic Health Evaluation (APACHE) II, which was 1 point higher in the nonsedation group than in the sedation group, indicating a greater chance of in-hospital death. The mean RASS score in the nonsedation group increased from -1.3 on day 1 to -0.8 on day 7 and, in the sedation group, from -2.3 on day 1 to -1.8 on day 7. Mortality at 90 days was 42.4% in the nonsedation group and 37.0% in the sedated group (difference, 5.4 percentage points; 95% confidence interval [CI], -2.2 to 12.2; P = 0.65). The number of ICU-free days and of ventilator-free days did not differ significantly between the trial groups. The patients in the nonsedation group had a median of 27 days free from coma or delirium, and those in the sedation group had a median of 26 days free from coma or delirium. A major thromboembolic event occurred in 1 patient (0.3%) in the nonsedation group and in 10 patients (2.8%) in the sedation group (difference, -2.5 percentage points; 95% CI, -4.8 to -0.7 [unadjusted for multiple comparisons]). Among mechanically ventilated ICU patients, mortality at 90 days did not differ significantly between those assigned to a plan of no sedation and those assigned to a plan of light sedation with daily interruption. (Funded by the Danish Medical Research Council and others; NONSEDA ClinicalTrials.gov number, NCT01967680.).

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D003128 Coma A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION. Comatose,Pseudocoma,Comas,Pseudocomas
D003693 Delirium A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2) Delirium of Mixed Origin,Subacute Delirium,Delirium, Subacute,Deliriums, Subacute,Mixed Origin Delirium,Mixed Origin Deliriums,Subacute Deliriums

Related Publications

Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
June 2020, The New England journal of medicine,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
June 1995, Critical care nursing clinics of North America,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
June 2005, Critical care (London, England),
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
January 2008, AACN advanced critical care,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
October 2012, American journal of respiratory and critical care medicine,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
September 2011, Critical care medicine,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
January 2011, Journal of burn care & research : official publication of the American Burn Association,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
April 2014, Journal of clinical monitoring and computing,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
August 2013, Critical care medicine,
Hanne T Olsen, and Helene K Nedergaard, and Thomas Strøm, and Jakob Oxlund, and Karl-Andre Wian, and Lars M Ytrebø, and Bjørn A Kroken, and Michelle Chew, and Serkan Korkmaz, and Jørgen T Lauridsen, and Palle Toft
June 2013, Critical care (London, England),
Copied contents to your clipboard!